You are here

News

subscribe

The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.

15 August 2017

Criminalising drug users linked to increased HIV levels

A ground-breaking review provides stark evidence of the damage criminalisation has on preventing and treating HIV among people who inject drugs.

0
03 August 2017

Injectable antiretroviral drugs – a ‘remarkable milestone’

Long-lasting antiretroviral drugs injected monthly present a ‘remarkable milestone’ in treatment options for people living with HIV

0
28 July 2017

Focusing on those with advanced HIV in the era of 'Treat All'

In the era of treat all, renewed emphasis is needed on the 39% of people living with HIV who start treatment late who are at an increased risk of deaths and opportunistic infections.

0
20 July 2017

HIV drug resistance is rising and needs urgent attention, says World Health Organization

Without urgent action, HIV drug resistance is set to derail the HIV response and presents a significant threat to public health, the World Health Organization (WHO) warns today.

0
27 June 2017

Hepatitis C, HIV and tuberculosis cause greatest harm for drug users globally

The UNODC highlights disease burden, increased opioid abuse and a lack of treatment access in their global state of drug use report.

0
16 June 2017

One in three people with HIV start treatment late in low- and middle-income countries

World Health Organization (WHO) guidelines call for all people newly diagnosed to start treatment straight away – but worrying numbers of people in high-burden countries still test and present late to care.

0
13 June 2017

Cryptococcal meningitis remains a leading killer of people living with HIV

First update on cryptococcus in the era of antiretroviral treatment expansion reveals disproportionate burden in sub-Saharan Africa and a need for better treatment options.

0
02 June 2017

People living with HIV have increased risk of neurocognitive impairment when they grow older

In the era of highly active antiretroviral treatment, HIV-associated neurocognitive disorders (HAND) still affect people living with HIV as they get older

0
21 February 2017

Pre-treatment drug resistance as high as 17% with no impact on viral load suppression

‘Surprising’ research from Conference on Retroviruses and Opportunistic Infections (CROI) shows drug resistance does not impact test-and-treat roll-out in South Africa – at least in the short term.

0
21 December 2016

Experimental PrEP drug injected once every two months to begin global trial

Adherence challenges with pre-exposure prophylaxis (PrEP) could be overcome if experimental long-acting HIV drug is found to be effective and acceptable.

0